ClassID:

95252

C07D403/12 - page 9 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#2401
20190127336
2019-05-02

Substituted quinazoline compounds and methods of use

#2402
20190127335
2019-05-02

Aurora kinase and Janus kinase inhibitors for prevention of graft versus host disease

#2403
20190127327
2019-05-02

Carbazole derivative and organic light emitting element using same

#2404
20190127323
2019-05-02

Beta lactams as modulators of glutamate uptake and methods for use thereof

#2405
20190125746
2019-05-02

Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents

#2406
20190125744
2019-05-02

Lanthionine synthetase C-like 2-based therapeutics

#2407
20190119268
2019-04-25

HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

#2408
20190119261
2019-04-25

N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease

#2409
20190119247
2019-04-25

APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#2410
20190119245
2019-04-25

Indole carboxamide compounds

#2411
20190119223
2019-04-25

Modulators of indoleamine 2,3-dioxygenase

#2412
20190119222
2019-04-25

Anti-inflammatory agents

#2413
20190119220
2019-04-25

Carboxylic acid compounds

#2414
20190119219
2019-04-25

PKM2 modulators and methods for their use

#2415
20190117654
2019-04-25

Compounds and their use for reducing uric acid levels

#2416
20190117650
2019-04-25

Substituted 2,4-diaminopyrimidines as kinase inhibitors

#2417
20190115543
2019-04-18

Amine-based compound and organic light-emitting device including the amine-based compound

#2418
20190112318
2019-04-18

Compounds, compositions and methods

#2419
20190112317
2019-04-18

ACTIVATORS OF AUTOPHAGIC FLUX AND PHOSPHOLIPASE D AND CLEARANCE OF PROTEIN AGGREGATES INCLUDING TAU AND TREATMENT OF PROTEINOPATHIES

#2420
20190112297
2019-04-18

N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides

#2421
20190112296
2019-04-18

N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activity

#2422
20190112295
2019-04-18

N-[(pyrimidinyloxy)propanyl]benzamides

#2423
20190112292
2019-04-18

N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity

#2424
20190112289
2019-04-18

D-amino acid oxidase inhibitors and therapeutic uses thereof

#2425
20190106430
2019-04-11

3-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#2426
20190106414
2019-04-11

Substituted-indole-compounds as estrogen receptor down-regulators

#2427
20190106402
2019-04-11

Physical form of a SGR modulator

#2428
20190106393
2019-04-11

[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof

#2429
20190105646
2019-04-11

Ion pair catalysis of tungstate and molybdate

#2430
20190100536
2019-04-04

Androgen receptor modulating compounds

#2431
20190100528
2019-04-04

EGFR inhibitor, preparation method and use thereof

#2432
20190100505
2019-04-04

INHIBITORS OF BRUTON'S TYROSINE KINASE

#2433
20190100497
2019-04-04

3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#2434
20190092765
2019-03-28

N-CYCLOALKYL-N-[(HETEROCYCLYLPHENYL)METHYLENE]-(THIO)CARBOXAMIDE DERIVATIVES

#2435
20190092758
2019-03-28

Blocking toll-like receptor 9 signaling with small molecule antagonist

#2436
20190092757
2019-03-28

Therapeutic polymeric nanoparticles and methods of making and using same

#2437
20190092735
2019-03-28

Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators

#2438
20190091235
2019-03-28

Compositions and therapeutic methods for the treatment of complement-associated diseases

#2439
20190091222
2019-03-28

Benzathine analogs

#2440
20190085024
2019-03-21

Alpha-Ketoamide Inhibitors Of Cysteine Proteases

#2441
20190085005
2019-03-21

Phosphonate compounds for treatment of complement mediated disorders

#2442
20190084990
2019-03-21

Small molecule myristate inhibitors of BCR-ABL and methods of use

#2443
20190084975
2019-03-21

Substituted pyrimidines as LRKK2 inhibitors

#2444
20190084972
2019-03-21

Pyrimidinyloxy benzene derivatives as herbicides

#2445
20190084966
2019-03-21

Synthetic route to anti-viral agents

#2446
20190084933
2019-03-21

Indole derivatives for use in medicine

#2447
20190084932
2019-03-21

Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same

#2448
20190084928
2019-03-21

METHOD FOR PRODUCING NITROGEN-CONTAINING AROMATIC AMIDE, METHOD FOR PRODUCING PYRROLE-IMIDAZOLE POLYAMIDE, AND COMPOUND

#2449
20190077795
2019-03-14

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#2450
20190077794
2019-03-14

Compositions and methods for treating infections

#2451
20190077793
2019-03-14

Bisamide sarcomere activating compounds and uses therof

#2452
20190077768
2019-03-14

Administration of aurora kinase inhibitors for anti-malarial therapy

#2453
20190077767
2019-03-14

Voltage-dependent t-type calcium channel blocker

#2454
20190077766
2019-03-14

Compositions for APP-selective BACE inhibition and uses therefor

#2455
20190076419
2019-03-14

Modulators of ATP-binding cassette transporters

#2456
20190071454
2019-03-07

Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine

#2457
20190071431
2019-03-07

3-phosphoglycerate dehydrogenase inhibitors and uses thereof

#2458
20190071424
2019-03-07

Wnt signaling pathway inhibitors for treatments of disease

#2459
20190071399
2019-03-07

Indole derivatives and their use as protein kinase inhibitors

#2460
20190070173
2019-03-07

Combinations for the treatment of neuroblastoma

#2461
20190070149
2019-03-07

PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#2462
20190070146
2019-03-07

Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

#2463
20190069554
2019-03-07

Use of tetrazolinones for combating resistant phytopathogenic fungi on soybean

#2464
20190062352
2019-02-28

Substituted asymmetric ureas as modulators of ghrelin receptor activity

#2465
20190062324
2019-02-28

Autotaxin inhibitors

#2466
20190062311
2019-02-28

Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors

#2467
20190062306
2019-02-28

Benzazepine compounds, conjugates, and uses thereof

#2468
20190062282
2019-02-28

Heterocycle and carbocycle derivatives having TRKA inhibitory activity

#2469
20190060282
2019-02-28

Imidazolylamide derivative

#2470
20190059377
2019-02-28

Fungicidal pyrazoles

#2471
20190055269
2019-02-21

Heteroaryl inhibitors of PDE4

#2472
20190055254
2019-02-21

Pyrrolobenzodiazepines

#2473
20190055242
2019-02-21

Inhibitors of lysine specific demethylase-1

#2474
20190055239
2019-02-21

Glycosidase inhibitors

#2475
20190055232
2019-02-21

Compounds

#2476
20190055223
2019-02-21

Toxin and method for preparing intermediate thereof

#2477
20190055219
2019-02-21

Indole derivatives and uses thereof

#2478
20190055218
2019-02-21

AHR inhibitors and uses thereof

#2479
20190055203
2019-02-21

Potent dual BRD4-kinase inhibitors as cancer therapeutics

#2480
20190055202
2019-02-21

Pyrimidines and variants thereof, and uses therefor

#2481
20190055200
2019-02-21

Catalytic hydrogenation process for preparing pyrazoles

#2482
20190054455
2019-02-21

N-heterocyclic carbene (NHC) based ligands and related methods

#2483
20190054068
2019-02-21

Indole Amide Derivatives and Related Compounds for Use in the Treatment of Neurodegenerative Diseases

#2484
20190048033
2019-02-14

Ether compounds for treatment of complement mediated disorders

#2485
20190047995
2019-02-14

Substituted pyrazin-2-amines as inhibitors of ATR kinase

#2486
20190047989
2019-02-14

Aryl substituted pyrimidines for use in influenza virus infection

#2487
20190047982
2019-02-14

Substituted 2-(het)arylimidazolylcarboxyamides as pesticides

#2488
20190047979
2019-02-14

Sulfonyl amide derivatives for the treatment of abnormal cell growth

#2489
20190047978
2019-02-14

1,2,4-triazine-4-amine derivatives

#2490
20190047968
2019-02-14

6-ACYL-1,2,4-TRIAZINE-3,5-DIONE DERIVATIVE AND HERBICIDES

#2491
20190047964
2019-02-14

Urea compound, preparation method therefor and medical use thereof

#2492
20190045783
2019-02-14

Substituted imidazolylcarboxamides as pesticides

#2493
20190040073
2019-02-07

NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF

#2494
20190040043
2019-02-07

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

#2495
20190040042
2019-02-07

Substituted 2-oxyimidazolylcarboxamides as pesticides

#2496
20190040021
2019-02-07

Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions

#2497
20190038626
2019-02-07

Heat shock protein binding compounds, compositions, and methods for making and using same

#2498
20190038604
2019-02-07

BICYCLIC COMPOUND, PRODUCTION AND USE THEREOF

#2499
20190038600
2019-02-07

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES

#2500
20190031692
2019-01-31

Compounds for treatment of complement mediated disorders

#2501
20190031658
2019-01-31

Benzamide and nicotinamide compounds and methods of using same

#2502
20190031607
2019-01-31

Therapeutic compounds and methods of use thereof

#2503
20190031605
2019-01-31

Tetrahydronaphthalene derivative

#2504
20190030031
2019-01-31

Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders

#2505
20190023729
2019-01-24

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#2506
20190023693
2019-01-24

Solid forms of Selinexor and process for their preparation

#2507
20190023665
2019-01-24

Small molecule agonists of neurotensin receptor 1

#2508
20190022066
2019-01-24

Pyrazole derivatives and their uses thereof

#2509
20190016729
2019-01-17

Process for making beta 3 agonists and intermediates

#2510
20190016715
2019-01-17

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

#2511
20190016705
2019-01-17

Cot modulators and methods of use thereof

#2512
20190016690
2019-01-17

Nuclear transport modulators and uses thereof

#2513
20190016688
2019-01-17

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#2514
20190016682
2019-01-17

Azepane derivatives and methods of treating hepatitis B infections

#2515
20190015413
2019-01-17

Acrylanilide derivative, preparation method, and applications thereof in pharmacy

#2516
20190013479
2019-01-10

Compound for organic-electric element, organic-electric element using same, and electronic device for same

#2517
20190010154
2019-01-10

Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group

#2518
20190010128
2019-01-10

1-ARYL-3-AMINOALKOXY PYRAZOLES AS SIGMA LIGANDS ENHANCING ANALGESIC EFFECT OF OPIOIDS AND ATTENUATING THE DEPENDENCY THEREOF

#2519
20190010122
2019-01-10

2-cyanoisoindoline derivatives for treating cancer

#2520
20190008833
2019-01-10

Nuclear transport modulators and uses thereof

#2521
20190006602
2019-01-03

Organic light emitting element

#2522
20190002454
2019-01-03

NRF2 Regulators

#2523
20190002439
2019-01-03

Heteroaromatic compounds and their use as dopamine D1 ligands

#2524
20190002412
2019-01-03

Pyrimidines as sodium channel blockers

#2525
20190000856
2019-01-03

MTH1 inhibitors for treatment of inflammatory and autoimmune conditions

#2526
20190000844
2019-01-03

Methods for treating Huntington's disease

#2527
20180370974
2018-12-27

Compounds and their use as inhibitors of N-myristoyl transferase

#2528
20180370955
2018-12-27

Tank-binding kinase inhibitor compounds

#2529
20180370954
2018-12-27

Process for the preparation of macitentan

#2530
20180370953
2018-12-27

Bis-triazole compounds with anti-biofilm and anti-corrosion properties

#2531
20180369242
2018-12-27

EGFR and ALK dual inhibitor

#2532
20180369227
2018-12-27

Alkyl dihydroquinoline sulfonamide compounds

#2533
20180369226
2018-12-27

Alkynyl dihydroquinoline sulfonamide compounds

#2534
20180369202
2018-12-27

CHK1/2 inhibitors and irinotecan for use in the treatment of rhabdomyosarcoma

#2535
20180369197
2018-12-27

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

#2536
20180362511
2018-12-20

Dimeric contrast agents

#2537
20180362498
2018-12-20

Forms and compositions of an ERK inhibitor

#2538
20180362475
2018-12-20

Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death

#2539
20180362471
2018-12-20

Substituted heterocyclyl derivatives as CDK inhibitors

#2540
20180362470
2018-12-20

Arylazole compound and pest control agent

#2541
20180362461
2018-12-20

Pyrrolidine derivatives

#2542
20180362460
2018-12-20

Cyanopyrrolidine derivatives as inhibitors for DUBs

#2543
20180362416
2018-12-20

Isobaric mass labels having n',n'-dimeihyl piperazine-2-carboxylic acid reporter moieties

#2544
20180360832
2018-12-20

Inhibitors of human phosphatidylinositol 3-kinase delta

#2545
20180360046
2018-12-20

Benzamide compounds and their use as herbicides

#2546
20180354933
2018-12-13

Carbazole derivative and organic light emitting device using same

#2547
20180354930
2018-12-13

Phenylimidazole compound

#2548
20180354908
2018-12-13

Pharmaceutical compound

#2549
20180354907
2018-12-13

CANNABINOID RECEPTOR MODULATORS

#2550
20180354906
2018-12-13

Human plasma kallikrein inhibitors

#2551
20180346450
2018-12-06

Trk inhibition

#2552
20180346449
2018-12-06

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

#2553
20180346441
2018-12-06

Substituted benzamides useful as sodium channel blockers

#2554
20180346423
2018-12-06

Pyridine compounds as fungicides

#2555
20180346420
2018-12-06

Carbon monoxide releasing norbornenone compounds

#2556
20180344723
2018-12-06

Rho kinase inhibitors

#2557
20180339993
2018-11-29

AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS

#2558
20180339981
2018-11-29

Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging

#2559
20180339979
2018-11-29

TGF-ß inhibitors

#2560
20180339970
2018-11-29

Pyrazole MAGL inhibitors

#2561
20180334451
2018-11-22

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

#2562
20180334450
2018-11-22

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

#2563
20180334439
2018-11-22

Antimicrobial Compounds And Methods Of Making And Using The Same

#2564
20180334438
2018-11-22

PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF

#2565
20180333390
2018-11-22

Compositions, methods of use, and methods of treatment

#2566
20180327428
2018-11-15

Process of making cenicriviroc and related analogs

#2567
20180327416
2018-11-15

Pyrazole compounds and methods of making and using same

#2568
20180327413
2018-11-15

Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors

#2569
20180327391
2018-11-15

Compound, compositions, and methods

#2570
20180327388
2018-11-15

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#2571
20180327365
2018-11-15

Substituted hydroxypyrimidinones for treating bacterial infections

#2572
20180327363
2018-11-15

Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis

#2573
20180326100
2018-11-15

Radiolabeled Tracers for Poly (ADP-RIBOSE) Polymerase-1 (PARP-1), Methods and Uses Therefor

#2574
20180325900
2018-11-15

Inhibitors of lysine specific demethylase-1

#2575
20180325873
2018-11-15

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

#2576
20180325868
2018-11-15

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

#2577
20180319818
2018-11-08

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#2578
20180319775
2018-11-08

Inhibitors of KRAS G12C mutant proteins

#2579
20180318456
2018-11-08

Compositions, methods, and systems for the synthesis and use of imaging agents

#2580
20180318299
2018-11-08

Heteroaryl compounds as BTK inhibitors and uses thereof

#2581
20180318255
2018-11-08

Pro-Neurogenic Compounds

#2582
20180312530
2018-11-01

PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES

#2583
20180312527
2018-11-01

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#2584
20180312526
2018-11-01

Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

#2585
20180312524
2018-11-01

Benzopiperazine compositions as BET bromodomain inhibitors

#2586
20180312503
2018-11-01

Nitrogen-containing aromatic heterocyclic compound

#2587
20180312500
2018-11-01

ANTI-ALPHAVBETA1 INTEGRIN COMPOUNDS AND METHODS

#2588
20180312490
2018-11-01

C5-anilinoquinazoline compounds and their use in treating cancer

#2589
20180312489
2018-11-01

Substituted indazole compounds as RORgammaT inhibitors and uses thereof

#2590
20180312485
2018-11-01

Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors

#2591
20180312474
2018-11-01

KDM1A inhibitors for the treatment of disease

#2592
20180312462
2018-11-01

Benzamide derivative

#2593
20180311254
2018-11-01

DNA-PK INHIBITORS

#2594
20180311242
2018-11-01

PYRIMIDINEDIONE COMPOUNDS

#2595
20180305383
2018-10-25

Kinase inhibitors

#2596
20180305347
2018-10-25

METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL

#2597
20180305341
2018-10-25

IMIDAZOLINONE DERIVATIVES AS TRPM8 ANTAGONISTS

#2598
20180305338
2018-10-25

Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

#2599
20180305336
2018-10-25

Histone demethylase inhibitors

#2600
20180305334
2018-10-25

COMPOUNDS, COMPOSITIONS AND METHODS OF USE AGAINST STRESS GRANULES

#2601
20180305326
2018-10-25

Disubstituted 1, 2, 4-triazine compound

#2602
20180305322
2018-10-25

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

#2603
20180305312
2018-10-25

EBNA1 inhibitors and methods using same

#2604
20180303855
2018-10-25

Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity

#2605
20180298043
2018-10-18

Alkyne Compounds for Treatment of Complement Mediated Disorders

#2606
20180298012
2018-10-18

Octahydropyrrolopyrroles their preparation and use

#2607
20180297948
2018-10-18

Sodium channel blockers

#2608
20180295839
2018-10-18

Herbicidal compounds

#2609
20180291047
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#2610
20180291046
2018-10-11

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

#2611
20180291021
2018-10-11

Substituted 6a,7,8,9,10,12-hexahydrobenzo[e]pyrido[1,2-a][1,4]diazepines as anti-proliferative agents

#2612
20180291012
2018-10-11

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer

#2613
20180290988
2018-10-11

Modulators of indoleamine 2,3-dioxygenase

#2614
20180290984
2018-10-11

BRD4-kinase inhibitors as cancer therapeutics

#2615
20180290982
2018-10-11

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#2616
20180290975
2018-10-11

Inhibitors of EGFR and methods of use thereof

#2617
20180290974
2018-10-11

Urea derivative or pharmacologically acceptable salt thereof

#2618
20180289718
2018-10-11

FUSED IMIDAZOLE COMPOUNDS

#2619
20180289703
2018-10-11

Lanthionine synthetase C-like 2-based therapeutics

#2620
20180289675
2018-10-11

Nuclear transport modulators and uses thereof

#2621
20180289672
2018-10-11

Substituted indazole derivatives active as kinase inhibitiors

#2622
20180282343
2018-10-04

CARM1 inhibitors and uses thereof

#2623
20180282341
2018-10-04

3-(CARBOXYMETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#2624
20180282318
2018-10-04

Dopamine D3 receptor antagonists

#2625
20180282309
2018-10-04

1,2-substituted cyclopentanes as orexin receptor antagonists

#2626
20180282308
2018-10-04

Inhibitors of KRAS G12C mutant proteins

#2627
20180282307
2018-10-04

Inhibitors of KRAS G12C mutant proteins

#2628
20180282302
2018-10-04

Heterocyclic compounds useful as Pim kinase inhibitors

#2629
20180282290
2018-10-04

Acylated N-(1 ,2,5-oxadiazol-3-yl)-, N-(1,3,4-oxadiazol-2-yl)-, N-(tetrazol-5-yl)- and N-(triazol-5-yl)-aryl carboxamides, and use thereof as herbicides

#2630
20180282289
2018-10-04

Azole derivatives as apelin receptor agonist

#2631
20180282276
2018-10-04

Compound for organic electric element, organic electric element comprising the same and electronic device thereof

#2632
20180282272
2018-10-04

SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS

#2633
20180273521
2018-09-27

Hepatitis B core protein allosteric modulators

#2634
20180273520
2018-09-27

Hepatitis B core protein modulators

#2635
20180273515
2018-09-27

Inhibitors of KRAS G12C mutant proteins

#2636
20180273505
2018-09-27

Inhibitors of lysine specific demethylase-1

#2637
20180273491
2018-09-27

3-(CARBOXYETHYL)-8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES

#2638
20180273485
2018-09-27

CANNABINOID RECEPTOR MEDIATING COMPOUNDS

#2639
20180271860
2018-09-27

Pharmaceutical compounds

#2640
20180271824
2018-09-27

N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

#2641
20180265518
2018-09-20

Apelin receptor (APJ) agonists and uses thereof

#2642
20180265504
2018-09-20

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

#2643
20180265503
2018-09-20

Compositions and methods for inhibition of the JAK pathway

#2644
20180265499
2018-09-20

Biaryl piperidine amide compounds and methods of use thereof

#2645
20180265491
2018-09-20

Inhibitors of lysine specific demethylase-1

#2646
20180265484
2018-09-20

Hepatitis B core protein modulators

#2647
20180258134
2018-09-13

PSMA imaging agents

#2648
20180258098
2018-09-13

Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them

#2649
20180258097
2018-09-13

HIV inhibitor compounds

#2650
20180258084
2018-09-13

Hepatitis B core protein modulators

#2651
20180258077
2018-09-13

5-SULFANYLHISTIDINES AND THEIR DISULFIDES AND METHOD OF PREPARATION THEREOF

#2652
20180258076
2018-09-13

Substituted imidazoles as melanocortin receptor agonists

#2653
20180258075
2018-09-13

Substituted 1H-indole-2-carboxamide compounds as indoleamine-2,3-dioxygenase inhibitors

#2654
20180258074
2018-09-13

Heterocyclic indoles for use in influenza virus infection

#2655
20180258056
2018-09-13

AMINO QUINAZOLINES AS KINASE INHIBITORS

#2656
20180258049
2018-09-13

Human plasma kallikrein inhibitors

#2657
20180258048
2018-09-13

Benzazepine compounds, conjugates, and uses thereof

#2658
20180258038
2018-09-13

N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS

#2659
20180256575
2018-09-13

Pyrimidinone amide compounds as PDE2 inhibitors

#2660
20180254427
2018-09-06

Compound and organic light-emitting element comprising same

#2661
20180251475
2018-09-06

Heterocyclic compounds and uses thereof

#2662
20180251458
2018-09-06

Histone demethylase inhibitors

#2663
20180251448
2018-09-06

Method for removing dimethoxybenzyl group

#2664
20180251432
2018-09-06

Amino pyrimidine derivatives

#2665
20180251430
2018-09-06

1-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-Yl)methoxy)ethyl)piperazin-1- Yl)ethanone salts

#2666
20180251426
2018-09-06

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#2667
20180250307
2018-09-06

Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof

#2668
20180244673
2018-08-30

LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS

#2669
20180244657
2018-08-30

Rho kinase inhibitors

#2670
20180244656
2018-08-30

Metallo-beta-lactamase inhibitors

#2671
20180244651
2018-08-30

Wnt signaling pathway inhibitors and therapeutic applications thereof

#2672
20180244633
2018-08-30

[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof

#2673
20180244632
2018-08-30

HIV replication inhibiting pyrimidines

#2674
20180244631
2018-08-30

INHIBITION OF OLIG2 ACTIVITY

#2675
20180244617
2018-08-30

Isoindoline derivatives for use in the treatment of a viral infection

#2676
20180243438
2018-08-30

Drug-conjugates, conjugation methods, and uses thereof

#2677
20180243324
2018-08-30

Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity

#2678
20180237440
2018-08-23

Janus kinase 1 selective inhibitor and pharmaceutical use thereof

#2679
20180237402
2018-08-23

Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors

#2680
20180237398
2018-08-23

Urea derivative and use therefor

#2681
20180237397
2018-08-23

PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#2682
20180237391
2018-08-23

Octahydrocyclopentapyrroles, their preparation and use

#2683
20180235964
2018-08-23

CXCR-2 inhibitors for treating crystal arthropathy disorders

#2684
20180230162
2018-08-16

COMPOUNDS FOR THE INHIBITION OF CYCLOPHILINS AND USES THEREOF

#2685
20180230159
2018-08-16

DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

#2686
20180230133
2018-08-16

Preparation method of rociletinib

#2687
20180230132
2018-08-16

5-(5-(2-(3-aminopropdoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitfile (S)-lactate monohydrate

#2688
20180230109
2018-08-16

Triazole compounds as T-type calcium channel blockers

#2689
20180230108
2018-08-16

Heterocyclic compounds for the inhibition of PASK

#2690
20180230085
2018-08-16

1,4-disubstituted imidazole derivative

#2691
20180228893
2018-08-16

Combinations and uses thereof

#2692
20180228807
2018-08-16

Methods of synthesizing thyroid hormone analogs and polymorphs thereof

#2693
20180222916
2018-08-09

Functionalized NANOLUC inhibitors

#2694
20180222899
2018-08-09

Bis-heteroaryl derivatives as modulators of protein aggregation

#2695
20180222898
2018-08-09

Modulators of calcium release-activated calcium channel

#2696
20180222894
2018-08-09

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof

#2697
20180222862
2018-08-09

3-indol substituted derivatives, pharmaceutical compositions and methods for use

#2698
20180221367
2018-08-09

Compounds and their use as BACE inhibitors

#2699
20180215757
2018-08-02

Compounds and methods for inhibiting fascin

#2700
20180215755
2018-08-02

Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties